There are currently 22 active clinical trials seeking participants for Hepatitis C research studies. The states with the highest number of trials for Hepatitis C participants are California, Texas, New York and Florida.
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
NCT03135886
Recruiting
This study will test two active evidence-based "practice coaching" (PC) interventions to improve opioid treatment programs' (OTPs') provision and sustained implementation of on-site 1) HIV testing and linkage to care and 2) HIV/Hepatitis C virus (HCV) testing and linkage to care among patients seeking/receiving substance use disorder treatment. Aims are: Aim 1: To evaluate the effectiveness of the PC interventions on improving patient uptake of HIV testing in OTPs including the incremental imp... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
06/18/2024
Locations: Columbia University Medical Center, New York, New York
Conditions: HIV/AIDS, Hepatitis C, Substance Use Disorders, Opioid-use Disorder
Register for Updates
Blood Collection Biorepository for Liver Disease Research
NCT03025074
Recruiting
The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.
Gender:
All
Ages:
7 years and above
Trial Updated:
06/14/2024
Locations: University at Buffalo, Buffalo General Medical Center, Buffalo, New York
Conditions: Non-Alcoholic Steatohepatitis(NASH), Hepatitis C, Hepatitis B, Fibrosis, Cirrhosis, Fatty Liver, Obesity, Childhood, Bariatric Surgery Candidate
Register for Updates
Hepatitis C Lab Testing Comparison Study
NCT06380166
Recruiting
Hepatitis C (HCV) HCV antibody assays are the standard of care test used to screen for HCV, but confirmation of acute infection is relegated in the current US guidelines to polymerase chain reaction (PCR) which often takes multiple days and may result in a loss to follow up and treatment, especially in high prevalence populations. HCV core antigen is a new, research use only immunoassay intended for use on the Abbott Alinity i system, an FDA-cleared instrument for clinical chemistry and immunoas... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
06/14/2024
Locations: HealthPartners, Bloomington, Minnesota
Conditions: Hepatitis C
Register for Updates
Evaluation of Patients With Liver Disease
NCT00001971
Recruiting
The proposed study aims to evaluate, investigate, and follow-up patients suffering from acute and chronic liver disease. The study will focus on understanding diseases affecting the liver. Patients participating in the study will first undergo a routine check-up as an outpatient. They will be asked to provide blood and urine samples for laboratory testing and will undergo an ultrasound of the liver. Ultrasound examinations use sound waves to determine the size and texture of the liver. After th... Read More
Gender:
All
Ages:
Between 2 years and 100 years
Trial Updated:
06/14/2024
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland
Conditions: Liver Disease, Hepatitis D, Hepatitis C, Hepatitis B
Register for Updates
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
NCT05181826
Recruiting
To acquire blood samples from subjects for various purposes, including: i) determining the sensitivity and specificity of select DNA methylation markers for the detection of various types of cancer, ii) identifying benign conditions that may induce false positive or false negative results, and iii) defining the effects of potential interfering substances, such as chemotherapy drugs.
Gender:
All
Ages:
18 years and above
Trial Updated:
06/13/2024
Locations: Torrance Memorial Physician Network - Cancer Care, Redondo Beach, California +6 locations
Conditions: Cancer, Liver Cirrhosis, Chronic Hepatitis, Hepatitis B, Hepatitis C, Diabetes, COPD
Register for Updates
A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV
NCT05904470
Recruiting
This is an open-label trial to evaluate safety and efficacy of treatment with BEM + RZR in subjects with chronic HCV infection.
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
05/10/2024
Locations: Atea Study Site, San Antonio, Texas +50 locations
Conditions: Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C, Hepatic Cirrhosis, HCV
Register for Updates
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
NCT01644903
Recruiting
This study is being done to test blood, urine and tissue samples to see if this can help decide if CKD (Chronic Kidney Disease), AR (Acute Rejection) and HCV (Hepatitis C Virus) can be identified in its early stages. CKD damage to the kidneys, AR and HCV all lower the body's ability to function properly. Early detection of these conditions could assist with successful treatment and possibly lead to less repeat organ transplants.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/24/2024
Locations: Northwestern Memorial Hospital, Chicago, Illinois
Conditions: Liver Transplant, Hepatitis C, Chronic Kidney Disease, Acute Rejection
Register for Updates
Feasibility and Acceptability of HCV Treatment in Pregnancy
NCT06367465
Recruiting
Pregnant adults over the age of 18 who are seen in the Washington University obstetrics and gynecology, maternal fetal medicine or infectious diseases clinic or admitted to BJH with hepatitis C virus infection who have a history of past or current drug use Participant Duration: Approximately 1 year. Aims: Aim 1 - Evaluate adherence and treatment completion rates when glecaprevir-pibrentasvir is started during pregnancy for women who use drugs. Aim 2 - Evaluate patient experience with hepatit... Read More
Gender:
Female
Ages:
18 years and above
Trial Updated:
04/11/2024
Locations: Barnes Jewish Hospital, Saint Louis, Missouri +1 locations
Conditions: Hepatitis C, Pregnancy Complications
Register for Updates
The HOPE Study: Characterizing Patients With Hepatitis B and C
NCT02995252
Recruiting
This is an observational, longitudinal, prospective study for sample collection and evaluation for future therapy or disease progression of chronic hepatitis B and C. Participants will be seen on an annual basis with optional additional visits for up to 10 years and provide samples for research and evaluation of disease progression. In addition, there is a longitudinal sub-study for treatment of hepatitis B that will involve 2 years of treatment with tenofovir alafenamide and blood collections w... Read More
Gender:
All
Ages:
Between 18 years and 99 years
Trial Updated:
04/02/2024
Locations: Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland +1 locations
Conditions: Hepatitis B， Chronic, Hepatitis C
Register for Updates
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
NCT06179498
Recruiting
The Partner Navigation Intervention Study is a randomized controlled study (RCT) to assess the efficacy and mechanism of action of the first behavioral intervention to increase hepatitis C (HCV) treatment initiation among adult people who inject drugs (PWID).
Gender:
All
Ages:
18 years and above
Trial Updated:
03/28/2024
Locations: University of California, San Francisco, San Francisco, California
Conditions: Hepatitis C
Register for Updates
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
NCT04162938
Recruiting
The investigators will conduct a randomized controlled clinical trial study in an urban emergency department in Baltimore to determine the impact of an educational app which is based on Leventhal's Common-Sense Model of Illness Representations framework, on HCV-infected ED patient's hepatitis C virus (HCV) health belief and knowledge as well as the downstream outcomes of the HCV Continuum of Care (linkage to care rate, initiation of HCV antiviral treatment, and sustained virologic response). Fir... Read More
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
03/14/2024
Locations: Johns Hopkins University, Baltimore, Maryland
Conditions: Hepatitis C
Register for Updates
A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients
NCT04508907
Recruiting
This study is being done to determine the effectiveness of using a combination of two different drugs in preventing the transmission of HCV from a HCV positive donor to a HCV negative solid organ recipient.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/11/2024
Locations: Mayo Clinic in Arizona, Phoenix, Arizona
Conditions: Hepatitis C, Kidney Transplant; Complications, Heart Transplant Infection
Register for Updates